Bkemv (Eculizumab-Aeeb)

Overview

Bkemv is approved by the U.S. Food and Drug Administration (FDA) for the treatment of generalized myasthenia gravis in adults who test positive for anti-acetylcholine receptor (AchR) antibodies. Bkemv is a…

Imaavy (Nipocalimab-Aahu) for Myasthenia Gravis

Imaavy (nipocalimab-aahu) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis in adults and children aged 12…

Mestinon (Pyridostigmine)

Overview
Mestinon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis. Mestinon may also be referred to by its drug name, pyridostigmine.
Mestinon is in a class… read more

Rystiggo (Rozanolixizumab) for Generalized Myasthenia Gravis

Rystiggo (rozanolixizumab) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to treat adults with generalized myasthenia gravis (gMG).

Soliris (Eculizumab)

Overview
Soliris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis (gMG) in adults and children 6 and older who are anti-acetylcholine receptor (AChR)…

Ultomiris (Ravulizumab-cwvz)

Overview

Ultomiris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for treating adults living with generalized myasthenia gravis who are anti-acetylcholine receptor antibody-positive…

Uplizna (Inebilizumab-Cdon)

Overview
Uplizna is approved by the U.S. Food and Drug Administration (FDA) for the treatment of generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AChR) or anti-muscle…

Vyvgart (Efgartigimod alfa-fcab)

Overview Vyvgart is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with myasthenia gravis who have a specific type of antibody called anti-acetylcholine receptor antibody…

Zilbrysq (Zilucoplan) for Myasthenia Gravis

Zilbrysq (zilucoplan) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized myasthenia gravis (gMG) in…